Friend, it’s been over eight months since President Biden called for a review of how marijuana is scheduled as a controlled substance under federal law.  

This step forward shows that the federal government may be shifting its approach to marijuana. But the scheduling process and its implications are not widely well understood.

Now is your chance to learn more. Register to join us for Changes in Federal Approaches to Cannabis: Process and Impact, a free webinar this Thursday, June 22, from 12pm-2pm ET.  

I’m excited to be partnering with The Ohio State University Moritz College of Law Drug Enforcement and Policy Center to moderate a panel of experts for this informative event. Together, we will discuss the role of federal agencies in the scheduling review process, the legal implications of marijuana’s status as a controlled substance, and the potential impact of rescheduling marijuana or descheduling it entirely. We will consider impacts on criminalization, research, medical access, and the medical and adult use cannabis industries currently regulated by states. 

Check out the incredible speakers here and join the conversation.  

Since 1971, marijuana has been designated as a Schedule I drug. That means it is classified as having “a high potential for abuse, no currently accepted medical use in treatment, and a lack of accepted safety for use under medical supervision.” And it means marijuana is still illegal at the federal level despite all the progress we’ve made legalizing marijuana in the states.  

At DPA, we believe that no one should be criminalized for marijuana. That’s why we’ve been fighting to change how marijuana is scheduled for decades. We support descheduling marijuana to fully remove it from the Controlled Substances Act. It’s the only way to completely end federal marijuana prohibition. 

This Thursday, I’ll ask experts their thoughts on the process and impact of changing marijuana’s status at the federal level. Please register to join me in learning more.